Note: Ingredients listed on restricted chemical lists
EC/CAS
231-659-4/7681-11-0
Name of the chemical
potassium iodide
Concentration
>95
General Information
Version
6
Revision date
2024-02-12
Product name
Potassium iodide
Product Synonyms
Knollide; Potide
CAS No.
7681-11-0
Emergency telephone
001-800-227-6701, +32 14 57 52 11, 001-201-796-7100, +32 14 57 52 99, 001-800-424-9300, 001-703-527-3887, +41-44 251 51 51, +41-43 508 20 11
Icons in SDS
Company Information
company name
Thermo Fisher (Kandel) GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
begel.sdsdesk@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H372
Hazard statements
Code
Statements
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
CLP Classification - Regulation (EC) No 1272/2008 Classification of the substance or mixture
Physical hazards
Based on available data, the classification criteria are not met
Health hazards
Specific target organ toxicity - (repeated exposure) Category 1 (H372)
Environmental hazards
Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16
Signal word
Danger
Hazard statements
H372 - Causes damage to organs through prolonged or repeated exposure
Precautionary statements
P260 - Do not breathe dust/fume/gas/mist/vapors/spray P314 - Get medical advice/attention if you feel unwell
2.3 Other hazards
In accordance with Annex XIII of the REACH Regulation, inorganic substances do not require assessment This product does not contain any known or suspected endocrine disruptors
2.1 Classification of the substance or mixture
CLP Classification - Regulation (EC) No 1272/2008 Physical hazards Based on available data, the classification criteria are not met Health hazards Specific target organ toxicity - (repeated exposure) Category 1 (H372) Environmental hazards Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16
